Want to create an interactive transcript for this episode?
Podcast: Fast Five Medtech News Podcast
Episode: Masimo aims to reduce costs, Ascensia Diabetes Care inks new deal in Canada
Description: Aetna's policy update expanding access to Neuronetics NeuroStar represents a positive step towards increasing patient accessibility to innovative depression treatment options. Fast Five hosts Sean Whooley and Danielle Kirsh explain what NeuroStar is and the policy update that expands access to the technology.
Biostrap announced that it launched its new Kairos wearable device for data visualization of the autonomic nervous system. Such devices can potentially empower individuals to monitor their health metrics in real time. Hear how the technology works and what the company is doing for diagnostics for the nervous system.
Ascensia Diabetes Care's deal to integrate blood glucose...